EHC2013


Go to content

Program

Program Highlights

New workshops on Haematopathology and Transfusion Medicine will be introduced in addition to the already established Nursing Workshop.

New oral presentations and poster sessions compiled from the submitted abstracts. These sessions will offer the opportunity for investigators, particularly the younger researchers, to present their work.

An outstanding group of high profile speakers covering a range of exciting topics in both benign & malignant hematology.

The topics of the EHC2013 Conference will include Thrombosis, Haemostasis, Haemoglobinoapthies, Transfusion Medicine, Acute & Chronic Leukemias, MDS, Myeloproliferative Neoplasms, Lymphoma, Myeloma and many more.

Organised by

Endorsed by

In collaboration with

Supported by

 
 

Scientific Program (as of February 2013)

Thursday 07 March 2013

Print this Page

07.00 - 18.00

Registration

08.00-11.00

Evidence Based Nursing Care Workshop

08.00 - 08.30

SÚzary Syndrome, Mary Ann Monica

08.30 - 09.00

Moving Cancer Survivorship Forward with Focused Intervention, Mohammad Saleh

09.00 - 09.30

Pediatrics Palliative Care, Amal Al Haddad

09.30 - 10.00

Food Safety Issues in Hospitalized Immune- Compromised Patient, Farhia Saeed Abdirageh

10.00 - 10.30

Clinical Trials, What Every Nurse Needs to Know?, Khaled Al Qawasmeh

10.30 - 11.00

Panel Discussion

11.00 - 11.30

Coffee Break

11.30 - 12.30

Opening Ceremony

12.30 - 13.00

Industry Symposium sponsored by Pfizer

13.00 - 14.00

Lunch

14.00-18.30

SESSION I ITP/Thrombosis/Hemostasis
Endorsed by International Society of Thrombosis and Hemostasis (ISTH)

14.00 - 14.30

Diagnosis & Management of ITP in 2013, David Kuter

14.30 - 15.00

Diagnosis & Management of APS, Philip de Groot

15.00 - 15.30

Diagnosis & Management of VWD in 2013, Augusto Federici

15.30 - 16.00

Panel Discussion

16.00 - 16.30

Coffee Break

16.30 - 17.00

Management of Relapse/Refractory ITP, David Kuter

17.00 - 17.30

Anti-platelet Treatment after Thrombosis, Philip de Groot

17.30 - 18.00

Management of Acquired VWD, Augusto Federici

18.00 - 18.30

Panel Discussion

18.30 - 19.00

Industry Symposia sponsored by GlaxoSmithKline
Extending the Efficacy and Safety of Eltrombopag up to 4 Years in Treatment of Chronic Immune Thrombocytopenia,
Namir El Saadawi

 

Friday 08 March 2013

08.00-09.30

SESSION II Hemoglobinopathy

08.00 - 08.30

Non Transfusion Dependent Thalassemia (NTDT), Iron Overload, Ali Taher

08.30 - 09.00

Sickle Cell Disease Update and Treatment Options, Mariane De Montalembert

09.00 - 09.20

NTDT, Treatment Challenges, Ali Taher

09.20 - 09.30

Panel Discussion

09.30 - 10.00

Coffee Break

10.00-12.00

SESSION III MPN/MDS/Myeloma

10.00 - 10.25

Myeloproliferative Neoplasm: Current Diagnostic & Prognostic Tools, Ayalew Tefferi

10.25 - 10.50

Multiple Myeloma in 2013: From Bench to Bedside, Jesus San-Miguel

10.50 - 11.15

Myelodysplastic Syndrome: Treatment in 2013, Ayalew Tefferi

11.15 - 11.40

Smoldering Myeloma: To Treat or Not to Treat?, Jesus San-Miguel

11.40 - 12.00

Panel Discussion

12.00 - 13.30

Prayers and Lunch

13.30 - 14.00

Industry Symposium sponsored by Sanofi Oncology
Management of Relapsed Childhood Acute Lymphoblastic Leukemia,
Naser J. Al-Zein

14.00-16.00

SESSION IV Lymphoma & Leukemia (i)

14.00 - 14.30

Management of Early Stage Hodgkin Lymphoma: Is Radiation Necessary?, Andrew Zelenetz

14.30 - 15.00

Update on "Grey-zone Lymphomas": Aggressive New Entities in the WHO Classification, Robert Hasserjian

15.00 - 15.30

How do we Integrate FISH into Treatment in SLL/CLL, Andrew Zelenetz

15.30 - 16.00

Panel Discussion

16.00 - 16.30

Coffee Break

16.30-18.30

SESSION IV Lymphoma & Leukemia (ii)

16.30 - 17.00

Novel Strategies for Induction & Post Remission Therapy in AML, Alan Burnett

17.00 - 17.30

Update on the WHO Classification of AML, Robert Hasserjian

17.30 - 18.00

Innovative Approaches for Relapsed AML: Any Progress?, Alan Burnett

18.00 - 18.30

Panel Discussion

20.00 - 22.00

Conference Dinner

 

Saturday March 09 2013

09.00 - 09.30

Oral Presentations Session 1: Haemato-oncology

 

Can Immunophenotyping Predict Molecular Transcript Type in B-cell Acute
Lymphoblastic Leukemia (ALL): A Retrospective Analysis of 30 Cases of B-cell ALL
Positive for Various Recurrent Translocations,
Prateek Bhatia

 

Epidemiology and Hematological Presentation of Adult Leukemias in Yemen, Jameel
Al-Ghazaly

 

Meningioma 1 (MN1) expression: Refined Risk Stratification in Acute Myeloid Leukemia with Normal Cytogenetics, Lamia Ibrahem

 

Discussion

09.30 - 10.15

Oral Presentations Session 2: Haemoglobinopathy

 

Misdiagnosis of Hemoglobin D-Punjab/Beta Thalassemia is A Potential Pitfall in
Hemoglobinopathy Screening Programs: A Case Report,
Maisam L. Bakir

 

Prothrombotic Markers in Thalassemia Major Patients: A Paradigm Shift, Syed Irfan

 

Prevalence of Iron Overload Complications Among Patients With B Thalassemia
Major Treated at Dubai Thalassemia Centre,
Fatheya Khaja

 

Heterogeneity of The Spectrum of Beta Thalassemia Mutations in Iraq, Nasir Al-
Allawi

 

Discussion

10.15 - 11.00

Oral Presentations Session 3 : Blood Transfusion

 

To Determine the Frequency Red Cell Alloimmunization in Patients with B-Major -
Thalassemia and To Identify the Common Alloantibodies,
Asim Qidwai

 

A Pragmatic Approach to Embedding Patient Blood Management in a Tertiary
Hospital,
Aqif Mukhtar

 

Prevalence of Hemolytic Disease of the Newborn in Sebha Medical Center-Sebha,
Libya,
Abousaif Ali Alsharif

 

Comparison of Real Time Polymerase Reaction with Microscopy and OptiMAL for the
diagnosis of Malaria in Pakistan,
Saleem Khan

 

Discussion

11.00 - 11.30

Coffee Break

11.30-13.00

SESSION V Pediatric Hematology

Pathology and Laboratory Medicine Workshop

11.30 - 12.00

HLH: Diagnosis & Management,
Shakila Khan

Recent Concepts in Transfusion Medicine,
Reem AlRadwan

12.00 - 12.30

Management of Burkitt Lymphoma in
Children & Adolescent,
Shakila Khan

12.30 - 13.00

Panel Discussion

Hands on Hematopathology,
Robert Hasserjian

13.00 - 13.30

Industry symposium sponsored by
Sanofi
VTE prophylaxis in Medical Patients,
Ahmad Hamid Alrustamani

13.30 - 14.30

Closing remarks & Lunch

 

Print this Page

Latest News

> EHC website exceeds 6,000
...visitors from more than
...30 countries

> Dubai Health Authority
...supportes EHC 2013

> UAE MOH grants 17.5 credit ...hours for EHC 2013 delegates

> EHA grants 14.5 credit hours
...for EHC 2013 delegates

 

Important Dates

20 Feb 13

Final Program available Online

24 Feb 13

Visa applications is closed

27 Feb 13

Online registration
is closed

07 Mar 13

Welcome to
EHC 2013


Back to content | Back to main menu